On the Nomenclature of the Anti-Rh Typing Serums: Report of the Advisory Review Board

Abstract

The Advisory Review Board has considered 2 systems of nomenclature and has concluded that a compromise must be made in that both systems must be used on container labels and package labels. Because the Wiener system has priority, this terminology for the anti-Rh serums should appear first on the label, followed by the Fisher-Race terminology in parentheses. The package label and literature might also contain the description of the test by means of which the serum is to be used.